![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
MJ Fasco, JB Silkworth, DA Dunbar and LS Kaminsky
Wadsworth Center for Laboratories and Research, New York State Department of Health, Albany.
Small intestinal cytochromes P450 (P450s) provide potential first-pass metabolism of ingested xenobiotics. To investigate this system, this study addresses the procedure for elution of enterocytes from male rat small intestine, histological evaluation of the elution procedure, and assessment of the functional microsomal P450s in small intestine of untreated and induced rats, using warfarin metabolism as a probe. Histologically it was demonstrated that villous enterocytes are initially detached in sheets and are subsequently eluted without clear resolution into villous tip, midvillous, and lower villous cells, contrary to previous reports. Crypt cells are eluted after cells from the villus. The following functional P450s were identified, using stereo- and regioselectivity of warfarin metabolism, in small intestinal microsomes: P4502B1 in untreated rats, P4501A1 in beta- naphthoflavone-induced rats, P4502B1 in phenobarbital-induced rats, and P4503A1/2 in pregnenolone-16 alpha-carbonitrile-induced rats. In contrast to hepatic microsomes from untreated or induced rats, P4502C11 and -2C6 were not present or inducible by these inducing agents in rat intestine. Western immunoblots, warfarin assays, and P450 assays all indicated that beta-naphthoflavone induced P4501A1 in small intestinal villous and crypt cells, but in contrast to the liver neither apo- P4501A2 nor functional P4501A2 was induced.
This article has been cited by other articles:
|
|
 |
|
  T. Yamamoto, K. Ito, M. Honma, T. Takada, and H. Suzuki Cholesterol-Lowering Effect of Ezetimibe in Uridine Diphosphate Glucuronosyltransferase 1A-Deficient (Gunn) Rats Drug Metab. Dispos., September 1, 2007; 35(9): 1455 - 1458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q.-Y. Zhang, L. S. Kaminsky, D. Dunbar, J. Zhang, and X. Ding Role of Small Intestinal Cytochromes P450 in the Bioavailability of Oral Nifedipine Drug Metab. Dispos., September 1, 2007; 35(9): 1617 - 1623. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Naud, J. Michaud, C. Boisvert, K. Desbiens, F. A. Leblond, A. Mitchell, C. Jones, A. Bonnardeaux, and V. Pichette Down-Regulation of Intestinal Drug Transporters in Chronic Renal Failure in Rats J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 978 - 985. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. DeLozier, C.-C. Tsao, S. J. Coulter, J. Foley, J. A. Bradbury, D. C. Zeldin, and J. A. Goldstein CYP2C44, a New Murine CYP2C That Metabolizes Arachidonic Acid to Unique Stereospecific Products J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 845 - 854. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. S. Kaminsky and Q.-Y. Zhang THE SMALL INTESTINE AS A XENOBIOTIC-METABOLIZING ORGAN Drug Metab. Dispos., December 1, 2003; 31(12): 1520 - 1525. [Full Text] [PDF]
|
|
|
|
|
|
Q.-Y. Zhang, D. Dunbar, and L. S. Kaminsky CHARACTERIZATION OF MOUSE SMALL INTESTINAL CYTOCHROME P450 EXPRESSION Drug Metab. Dispos., November 1, 2003; 31(11): 1346 - 1351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. S. Poet, H. Wu, A. A. Kousba, and C. Timchalk In Vitro Rat Hepatic and Intestinal Metabolism of the Organophosphate Pesticides Chlorpyrifos and Diazinon Toxicol. Sci., April 1, 2003; 72(2): 193 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. Leblond, M. Petrucci, P. Dube, G. Bernier, A. Bonnardeaux, and V. Pichette Downregulation of Intestinal Cytochrome P450 in Chronic Renal Failure J. Am. Soc. Nephrol., June 1, 2002; 13(6): 1579 - 1585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Spivack, G. J. Hurteau, A. A. Reilly, K. M. Aldous, X. Ding, and L. S. Kaminsky CYP1B1 Expression in Human Lung Drug Metab. Dispos., June 1, 2001; 29(6): 916 - 922. [Abstract] [Full Text]
|
|
|
|
|
|
S. Ammon, O. von Richter, U. Hofmann, K.-P. Thon, M. Eichelbaum, and G. Mikus In Vitro Interaction of Codeine and Diclofenac Drug Metab. Dispos., October 1, 2000; 28(10): 1149 - 1152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-C. Tsao, J. Foley, S. J. Coulter, R. Maronpot, D. C. Zeldin, and J. A. Goldstein CYP2C40, a Unique Arachidonic Acid 16-Hydroxylase, Is the Major CYP2C in Murine Intestinal Tract Mol. Pharmacol., August 1, 2000; 58(2): 279 - 287. [Abstract] [Full Text]
|
|
|
|
|
|
Q.-Y. Zhang, X. Ding, D. Dunbar, L. Cao, and L. S. Kaminsky Induction of Rat Small Intestinal Cytochrome P-450 2J4 Drug Metab. Dispos., October 1, 1999; 27(10): 1123 - 1127. [Abstract] [Full Text]
|
|
|
|
|
|
Q.-Y. Zhang, D. Dunbar, A. Ostrowska, S. Zeisloft, J. Yang, and L. S. Kaminsky Characterization of Human Small Intestinal Cytochromes P-450 Drug Metab. Dispos., July 1, 1999; 27(7): 804 - 809. [Abstract] [Full Text]
|
|
|
|
|
|
P. A. Redondo, A. I. Álvarez, J. L. Garcia, O. M. Larrodé, G. Merino, and J. G. Prieto Presystemic Metabolism of Albendazole: Experimental Evidence of an Efflux Process of Albendazole Sulfoxide to Intestinal Lumen Drug Metab. Dispos., June 1, 1999; 27(6): 736 - 740. [Abstract] [Full Text]
|
|
|
|
|
|
D. C. Zeldin, J. Foley, S. M. Goldsworthy, M. E. Cook, J. E. Boyle, J. Ma, C. R. Moomaw, K. B. Tomer, C. Steenbergen, and S. Wu CYP2J Subfamily Cytochrome P450s in the Gastrointestinal Tract: Expression, Localization, and Potential Functional Significance Mol. Pharmacol., June 1, 1997; 51(6): 931 - 943. [Abstract] [Full Text]
|
|
|
|
|
|
Q.-Y. Zhang, J. Wikoff, D. Dunbar, M. Fasco, and L. Kaminsky Regulation of Cytochrome P4501A1 Expression in Rat Small Intestine Drug Metab. Dispos., January 1, 1997; 25(1): 21 - 26. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
